Barclays Maintains Overweight on Exelon, Raises Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Nicholas Campanella maintains an Overweight rating on Exelon (NASDAQ:EXC) and raises the price target from $39 to $41.
July 22, 2024 | 12:59 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Nicholas Campanella maintains an Overweight rating on Exelon and raises the price target from $39 to $41.
The raised price target and maintained Overweight rating from a reputable analyst at Barclays is likely to positively influence investor sentiment and drive short-term price appreciation for Exelon.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100